About Us
Our mission is to cure cancer through high performance, accessible early cancer detection. That means saving lives.
Delfi Diagnostics is a Johns Hopkins spinoff focused on the non-invasive detection of cancer at earlier stages, when it is most curable. DELFI uses artificial intelligence and whole-genome sequencing to detect unique patterns of DNA fragmentation in the blood of patients with cancer. These analyses are performed through simultaneous examination of millions of DNA sequences using machine learning to identify tumor-specific abnormalities.
In our passionate pursuit to radically improve health outcomes, we serve humanity when we:
Lead with Science, Anchor in Pragmatism: We pioneer life-changing science by ensuring quality, transparency, and rigor at all times.
Build With & For All: We embrace diverse backgrounds to innovate and achieve together. We are not just building a product—we aim to disrupt the path of cancer for all, no matter geography or socioeconomic class.
Put We over I: We are a home for high-performing people. Through teamwork, we build collective intelligence. Each of us wins when those we serve and those who serve with us win. We show up with empathy, humility, and integrity at every step of the journey.
About the Role
The VP, Clinical Development and Trial Innovation provides strategic leadership across DELFI’s clinical study portfolio, working closely with executive leadership and cross-functional teams including R&D, medical, quality, and regulatory. This leader defines and shapes the comprehensive strategy for all DELFI clinical studies while executing on our key trials supporting product development, launch, and reimbursement. We seek an adaptable, rigorous, future-thinking, and decisive leader who is solidly grounded in clinical development and will champion the use of AI to innovate on clinical trial efficiency. The role requires technical expertise in clinical study design and development, oncology, and preferably diagnostics product development.
